Surrey Heartlands

Joint Formulary & PAD

Flecainide acetate - Arrhythmias

You are here : Home > Formulary Search > Flecainide acetate - Arrhythmias

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :
Important
Specialist initiation and at least one month supply before transfer to primary care
 

Status 2

Red
Formulations :
  • Injection
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :
Important
Unlicensed. For use or advice by cardiology consultants only.

Documentation

Shared Care
Flecainide for arrhythmias - Amber Star Information Sheet - July 2015

PAD Profile

ChemicalSubstance :
Flecainide acetate
Indication :
Arrhythmias
Group Name :
Keywords :
supraventricular arrhythmias, ventricular arrhythmias
Brand Names Include :
Tambocor
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Flecainide acetate is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Arrhythmias.

Committee Recommendations (2)

03 May 17 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
GENERIC Flecainide has been considered by the PCN and has been assigned a BLUE traffic light status.

NOTE - the branded product, Tambocor, was considered BLACK at the PCN in May 2017.
01 Jul 15 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
The PCN supported the attached updated Amber* Information Sheet.